DAB2 and pancreatic neoplasm: A previous study in pancreatic cancer has shown that primary tumor samples exhibited upregulated Dab2 expression, with decreased Dab2 expression observed in lymph node metastases and metastatic pancreatic cell lines, suggesting that Dab2 acted as an inhibitor of late tumor progression and metastasis33.